Skip to main content
×
Home

Daily chocolate consumption is inversely associated with insulin resistance and liver enzymes in the Observation of Cardiovascular Risk Factors in Luxembourg study

  • Ala’a Alkerwi (a1), Nicolas Sauvageot (a1), Georgina E. Crichton (a1) (a2), Merrill F. Elias (a3) (a4) and Saverio Stranges (a1) (a5)...
Abstract
Abstract

This study examined the association of chocolate consumption with insulin resistance and serum liver enzymes in a national sample of adults in Luxembourg. A random sample of 1153 individuals, aged 18–69 years, was recruited to participate in the cross-sectional Observation of Cardiovascular Risk Factors in Luxembourg study. Chocolate consumption (g/d) was obtained from a semi-quantitative FFQ. Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance (HOMA-IR). Hepatic biomarkers such as serum γ-glutamyl-transpeptidase (γ-GT), serum aspartate transaminase and serum alanine transaminase (ALT) (mg/l) were assessed using standard laboratory assays. Chocolate consumers (81·8 %) were more likely to be younger, physically active, affluent people with higher education levels and fewer chronic co-morbidities. After excluding subjects taking antidiabetic medications, higher chocolate consumption was associated with lower HOMA-IR (β=−0·16, P=0·004), serum insulin levels (β=−0·16, P=0·003) and γ-GT (β=−0·12, P=0·009) and ALT (β=−0·09, P=0·004), after adjustment for age, sex, education, lifestyle and dietary confounding factors, including intakes of fruits and vegetables, alcohol, polyphenol-rich coffee and tea. This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin, HOMA-IR and liver enzymes in adults, suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance, a well-established risk factor for cardiometabolic disorders. Further observational prospective research and well-designed randomised-controlled studies are needed to confirm this cross-sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Daily chocolate consumption is inversely associated with insulin resistance and liver enzymes in the Observation of Cardiovascular Risk Factors in Luxembourg study
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Daily chocolate consumption is inversely associated with insulin resistance and liver enzymes in the Observation of Cardiovascular Risk Factors in Luxembourg study
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Daily chocolate consumption is inversely associated with insulin resistance and liver enzymes in the Observation of Cardiovascular Risk Factors in Luxembourg study
      Available formats
      ×
Copyright
Corresponding author
* Corresponding author: A. Alkerwi, fax +352 26 970 719, email alaa.alkerwi@lih.lu
References
Hide All
1. Rosamond WD, Chambless LE, Folsom AR, et al. (1998) Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 339, 861867.
2. Steinberger J & Daniels SR, American Heart Association Atherosclerosis Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young), et al. (2003) Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 107, 14481453.
3. Ginsberg HN (2000) Insulin resistance and cardiovascular disease. J Clin Invest 106, 453458.
4. McFarlane SI, Banerji M & Sowers JR (2001) Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 86, 713718.
5. Balkau B & Eschwege E (1999) Insulin resistance: an independent risk factor for cardiovascular disease? Diabetes Obes Metab 1, Suppl. 1, S23S31.
6. Ding EL, Hutfless SM, Ding X, et al. (2006) Chocolate and prevention of cardiovascular disease: a systematic review. Nutr Metab (Lond) 3, 2.
7. Corti R, Flammer AJ, Hollenberg NK, et al. (2009) Cocoa and cardiovascular health. Circulation 119, 14331441.
8. Lee KW, Kim YJ, Lee HJ, et al. (2003) Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem 51, 72927295.
9. Manach C, Scalbert A, Morand C, et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727747.
10. Di Castelnuovo A, di Giuseppe R, Iacoviello L, et al. (2012) Consumption of cocoa, tea and coffee and risk of cardiovascular disease. Eur J Intern Med 23, 1525.
11. Hertog MG, Kromhout D, Aravanis C, et al. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155, 381386.
12. Hertog MG, Feskens EJ, Hollman PC, et al. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 10071011.
13. Hartley L, Flowers N, Holmes J, et al. (2013) Green and black tea for the primary prevention of cardiovascular disease. The Cochrane Database of Systematic Reviews 2013, issue 6, CD009934.
14. Keli SO, Hertog MG, Feskens EJ, et al. (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen Study. Arch Intern Med 156, 637642.
15. Knekt P, Jarvinen R, Reunanen A, et al. (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312, 478481.
16. Gu Y, Yu S & Lambert JD (2014) Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice. Eur J Nutr 53, 149158.
17. Grassi D, Lippi C, Necozione S, et al. (2005) Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 81, 611614.
18. Grassi D, Desideri G, Necozione S, et al. (2008) Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 138, 16711676.
19. Alkerwi A, Sauvageot N, Donneau AF, et al. (2010) First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX). BMC Public Health 10, 468.
20. Alkerwi A, Sauvageot N, Couffignal S, et al. (2010) Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg. BMC Med Res Methodol 10, 80.
21. Sauvageot N, Alkerwi A, Albert A, et al. (2013) Validation of the food frequency questionnaire used to assess the association between dietary habits and cardiovascular risk factors in the NESCAV study. J Nutr Food Sci 3, 208.
22. Sauvageot N, Alkerwi A, Albert A, et al. (2013) Use of food frequency questionnaire to assess relationships between dietary habits and cardiovascular risk factors in NESCAV study: validation with biomarkers. Nutr J 12, 143.
23. Bonora E, Kiechl S, Willeit J, et al. (2007) Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care 30, 318324.
24. Alkerwi A, Sauvageot N, Nau A, et al. (2012) Population compliance with national dietary recommendations and its determinants: findings from the ORISCAV-LUX study. Br J Nutr 108, 20832092.
25. Alkerwi A, Donneau AF, Sauvageot N, et al. (2012) Dietary, behavioural and socio-economic determinants of the metabolic syndrome among adults in Luxembourg: findings from the ORISCAV-LUX study. Public Health Nutr 15, 849859.
26. Schisterman EF, Cole SR & Platt RW (2009) Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 20, 488495.
27. Mancia G, De Backer G, Dominiczak A, et al. (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25, 11051187.
28. Ryden L, Standl E, Bartnik M, et al. (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28, 88136.
29. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 10, S1S10.
30. Buitrago-Lopez A, Sanderson J, Johnson L, et al. (2011) Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ 343, d4488.
31. Hooper L, Kroon PA, Rimm EB, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88, 3850.
32. Murphy MM, Barraj LM, Bi X, et al. (2013) Body weight status and cardiovascular risk factors in adults by frequency of candy consumption. Nutr J 12, 53.
33. Steinberg FM, Bearden MM & Keen CL (2003) Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc 103, 215223.
34. Brand-Miller J, Holt SH, de Jong V, et al. (2003) Cocoa powder increases postprandial insulinemia in lean young adults. J Nutr 133, 31493152.
35. Grassi D, Necozione S, Lippi C, et al. (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398405.
36. Carrieri MP, Lions C, Sogni P, et al. (2014) Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study. J Hepatol 60, 4653.
37. Selmi C, Cocchi CA, Lanfredini M, et al. (2008) Chocolate at heart: the anti-inflammatory impact of cocoa flavanols. Mol Nutr Food Res 52, 13401348.
38. Katz DL, Doughty K & Ali A (2011) Cocoa and chocolate in human health and disease. Antioxid Redox Signal 15, 27792811.
39. Zeng G, Nystrom FH, Ravichandran LV, et al. (2000) Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101, 15391545.
40. Potenza MA, Marasciulo FL, Tarquinio M, et al. (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292, E1378E1387.
41. Golomb BA, Koperski S & White HL (2012) Association between more frequent chocolate consumption and lower body mass index. Arch Intern Med 172, 519521.
42. Greenberg JA & Buijsse B (2013) Habitual chocolate consumption may increase body weight in a dose-response manner. PLOS ONE 8, e70271.
43. Cuenca-Garcia M, Ruiz JR, Ortega FB, et al. (2014) Association between chocolate consumption and fatness in European adolescents. Nutrition 30, 236239.
44. Greenberg JA, Manson JE, Buijsse B, et al. (2015) Chocolate-candy consumption and 3-year weight gain among postmenopausal U.S. women. Obesity (Silver Spring) 23, 677683.
45. Buijsse B, Feskens EJ, Kok FJ, et al. (2006) Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med 166, 411417.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 85
Total number of PDF views: 431 *
Loading metrics...

Abstract views

Total abstract views: 3468 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 12th December 2017. This data will be updated every 24 hours.